Economic cost associated with type II diabetes in Spanish patients

被引：28
作者：
Ballesta M. [1 ]
Carral F. [2 ,5 ]
Olveira G. [3 ]
Girón J.A. [4 ]
Aguilar M. [2 ]
机构：
[1] Primary Health Care District Bahía de Cádiz-La Janda, Cadiz
[2] Endocrinology and Nutrition Service, Puerta del Mar University Hospital, Cadiz
[3] Endocrinology and Nutrition Service, Carlos Haya University Hospital, Malaga
[4] Internal Medicine Service, Puerta del Mar University Hospital, Cadiz
[5] Servicio de Endocrinología Y Nutrición, Hospital Universitario Puerta del Mar, Cadiz 11009
来源：
The European Journal of Health Economics | 2006年 / 7卷 / 4期
关键词：
Complications; Cost; Diabetes type II; Economic costs; Metabolic control;
D O I：
10.1007/s10198-006-0367-9
中图分类号：
学科分类号：
摘要：
An observational descriptive study was carried out of the healthcare resources consumed during 1 year by a sample of patients with type II diabetes of a healthcare area in southern Spain. A total of 517 patients with a mean duration of disease of 9.7±8 years were assessed. A total annual health cost of €4,278/patient was calculated (direct €2,504; indirect €1,774). Multiple regression analysis showed an independent association between total costs and obesity, male sex, number of hospitalizations related to diabetes, permanent disability, macrovascular complications, and both micro- and macrovascular complications. Our findings confirm both the high economic cost associated with type II diabetes and the direct relationship between the costs of the disease and the presence of obesity, male sex, hospitalizations related to diabetes, permanent disability and chronic complications. © 2006 Springer Medizin Verlag.
引用
收藏
页码：270 / 275
页数：5
相关论文
共 25 条
  • [1] King H., Aubert R.E., Herman W.H., Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections, Diabetes Care, 21, pp. 1414-1431, (1998)
  • [2] Carral F., Olveira G., Ramos I., Et al., Calidad de vida en pacientes con diabetes mellitus tipo 2 ingresados en un hospital de tercer nivel, Endocrinol Nutr, 47, pp. 24-28, (2000)
  • [3] Eiser C., Tooke J.E., Quality-of-life evaluation in diabetes, Pharmacoeconomics, 4, pp. 85-91, (1993)
  • [4] Rubin R.J., Altman W.M., Mendelson D.N., Health care expenditures for people with diabetes mellitus, 1992, J Clin Endocrinol Metab, 78, (1994)
  • [5] Economic costs of diabetes in the United States in 2002, Diabetes Care, 26, pp. 917-932, (2003)
  • [6] Economic consequences of diabetes mellitus in the United States in 1997, Diabetes Care, 21, pp. 296-309, (1998)
  • [7] Kangas T., Aro S., Koivisto V.A., Et al., Structure and costs of health care of diabetic patients in Finland, Diabetes Care, 19, pp. 494-497, (1996)
  • [8] Mata M., Antonanzas F., Tafalla M., Sanz P., El coste de la diabetes tipo 2 en España. El estudio CODE-2, Gac Sanit, 16, pp. 511-520, (2002)
  • [9] Krosnick A., Economic impact of type II diabetes mellitus, Prim Care, 15, pp. 423-432, (1988)
  • [10] Henriksson F., Jonsson B., Diabetes: The cost of illness in Sweden, J Intern Med, 244, pp. 461-468, (1998)
123